Arcus Biosciences, Inc.
SOLID FORMS OF A CD73 INHIBITOR AND THE USE THEREOF
Last updated:
Abstract:
Solid forms of Compound I, which modulates the conversion of AMP to adenosine by 5'-nucleotidase, ecto, and compositions containing the compound and methods for preparing the solid forms, are described herein. The use of such solid form of Compound I and compositions for the treatment and/or prevention of a diverse array of diseases, disorders and conditions, including cancer- and immune-related disorders, that are mediated by 5'-nucleotidase, ecto is also provided.
Status:
Application
Type:
Utility
Filling date:
12 Dec 2019
Issue date:
3 Mar 2022